256 related articles for article (PubMed ID: 37891632)
21. [Opioid overdose prevention and naloxone diffusion (POP program): Results of an overview conducted among addiction specialized centres].
Mezaache S; Turlure F; Fredon N; Le Brun Gadelius M; Micallef J; Frauger E
Therapie; 2023; 78(6):605-614. PubMed ID: 37012152
[TBL] [Abstract][Full Text] [Related]
22. A rapid-cycle assessment strategy for understanding the opioid overdose epidemic in local communities.
Taubenberger S; Spencer N; Chang JC; Paul N; Fabre S; Jagessar B; Trimble D; Roberto R; Gill P; Hulsey E; Arnold A; Hacker K
Subst Abus; 2021; 42(4):888-895. PubMed ID: 33689674
[No Abstract] [Full Text] [Related]
23. Providers' perceptions on barriers and facilitators to prescribing naloxone for patients at risk for opioid overdose after implementation of a national academic detailing program: A qualitative assessment.
Bounthavong M; Suh K; Christopher MLD; Veenstra DL; Basu A; Devine EB
Res Social Adm Pharm; 2020 Aug; 16(8):1033-1040. PubMed ID: 31706950
[TBL] [Abstract][Full Text] [Related]
24. It's what the community demands: Results of community-based emergency opioid overdose trainings.
Febres-Cordero S; Smith DJ; Wulkan AZ; Béliveau AJ; Gish A; Zine S; Fugitt L; Giordano NA
Public Health Nurs; 2023 Jan; 40(1):44-53. PubMed ID: 36377302
[TBL] [Abstract][Full Text] [Related]
25. [First Aid Training for Drug Overdose in Opioid Addicts and Provision of Take-Home Naloxone on Release from Prison: Feasibility Study from the Bavarian Model Project].
Wodarz-von Essen HJ; Wolstein J; Pogarell O; Wodarz N
Gesundheitswesen; 2023 Jun; 85(6):568-572. PubMed ID: 36126950
[TBL] [Abstract][Full Text] [Related]
26. Long-term effects of opioid overdose prevention and response training on medical student knowledge and attitudes toward opioid overdose: A pilot study.
Moses TEH; Chou JS; Moreno JL; Lundahl LH; Waineo E; Greenwald MK
Addict Behav; 2022 Mar; 126():107172. PubMed ID: 34774365
[TBL] [Abstract][Full Text] [Related]
27. Addiction stigma and the production of impediments to take-home naloxone uptake.
Fomiatti R; Farrugia A; Fraser S; Dwyer R; Neale J; Strang J
Health (London); 2022 Mar; 26(2):139-161. PubMed ID: 32529843
[TBL] [Abstract][Full Text] [Related]
28. Legal requirements and recommendations to prescribe naloxone.
Haffajee RL; Cherney S; Smart R
Drug Alcohol Depend; 2020 Apr; 209():107896. PubMed ID: 32058248
[TBL] [Abstract][Full Text] [Related]
29. Law enforcement attitudes toward overdose prevention and response.
Green TC; Zaller N; Palacios WR; Bowman SE; Ray M; Heimer R; Case P
Drug Alcohol Depend; 2013 Dec; 133(2):677-84. PubMed ID: 24051061
[TBL] [Abstract][Full Text] [Related]
30. Stigma by Association: To what Extent is the Attitude Toward Naloxone Affected by the Stigma of Opioid Use Disorder?
Adeosun SO
J Pharm Pract; 2023 Aug; 36(4):941-952. PubMed ID: 35505618
[TBL] [Abstract][Full Text] [Related]
31. A scoping review of post opioid-overdose interventions.
Bagley SM; Schoenberger SF; Waye KM; Walley AY
Prev Med; 2019 Nov; 128():105813. PubMed ID: 31437462
[TBL] [Abstract][Full Text] [Related]
32. Designing a public access naloxone program for public transportation stations.
Kohli S; Garg J; Velasquez DE; Weiner SG
Healthc (Amst); 2023 Jun; 11(2):100694. PubMed ID: 37247465
[TBL] [Abstract][Full Text] [Related]
33. Concerns that an opioid antidote could "make things worse": Profiles of risk compensation beliefs using the Naloxone-Related Risk Compensation Beliefs (NaRRC-B) scale.
Winograd RP; Werner KB; Green L; Phillips S; Armbruster J; Paul R
Subst Abus; 2020; 41(2):245-251. PubMed ID: 31170030
[No Abstract] [Full Text] [Related]
34. Identifying drivers of increasing opioid overdose deaths among black individuals: a qualitative model drawing on experience of peers and community health workers.
Banks DE; Duello A; Paschke ME; Grigsby SR; Winograd RP
Harm Reduct J; 2023 Jan; 20(1):5. PubMed ID: 36639769
[TBL] [Abstract][Full Text] [Related]
35. Evaluating the impact of naloxone dispensation at public health vending machines in Clark County, Nevada.
Allen ST; O'Rourke A; Johnson JA; Cheatom C; Zhang Y; Delise B; Watkins K; Reich K; Reich R; Lockett C
Ann Med; 2022 Dec; 54(1):2692-2700. PubMed ID: 36168975
[TBL] [Abstract][Full Text] [Related]
36. Hostility, compassion and role reversal in West Virginia's long opioid overdose emergency.
Ondocsin J; Mars SG; Howe M; Ciccarone D
Harm Reduct J; 2020 Oct; 17(1):74. PubMed ID: 33046092
[TBL] [Abstract][Full Text] [Related]
37. Training law enforcement to respond to opioid overdose with naloxone: Impact on knowledge, attitudes, and interactions with community members.
Wagner KD; Bovet LJ; Haynes B; Joshua A; Davidson PJ
Drug Alcohol Depend; 2016 Aug; 165():22-8. PubMed ID: 27262898
[TBL] [Abstract][Full Text] [Related]
38. Intranasal Naloxone for Opioid Overdose.
Taylor JL; Lasser KE
JAMA; 2024 Jan; 331(3):250-251. PubMed ID: 38127361
[TBL] [Abstract][Full Text] [Related]
39. "A Blessing and a Curse:" Opioid Users' Perspectives on Naloxone and the Epidemic of Opioid Overdose.
Kline A; Mattern D; Cooperman N; Dooley-Budsock P; Williams JM; Borys S
Subst Use Misuse; 2020; 55(8):1280-1287. PubMed ID: 32182153
[No Abstract] [Full Text] [Related]
40. How prepared are pharmacists to provide over-the-counter naloxone? The role of previous education and new training opportunities.
Lai Joyce Chun K; Olsen A; Taing MW; Clavarino A; Hollingworth S; Dwyer R; Middleton M; Nielsen S
Res Social Adm Pharm; 2019 Aug; 15(8):1014-1020. PubMed ID: 30926251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
